Document is current
Any future updates will be listed below
-
Authors
Ponsford, Mark J. https://orcid.org/0000-0002-0236-1059
Carne, Emily M.
Bramhall, Kathryn
Ladell, Kristin https://orcid.org/0000-0002-9856-2938
Perelygina, Ludmila https://orcid.org/0000-0003-0812-8124
Saw, Aung
Miners, Kelly
Llewellyn-Lacey, Sian
Kollnberger, Simon
Tully, Ian
Hughes, Sian
Williams, Hywel https://orcid.org/0000-0001-7758-0312
Kalavala, Manju
Bigley, Venetia https://orcid.org/0000-0002-3017-2474
Farewell, Daniel https://orcid.org/0000-0002-8871-1653
Price, David A. https://orcid.org/0000-0001-9416-2737
Walker, Stephen L. https://orcid.org/0000-0002-2034-8376
Sullivan, Kathleen E.
Jolles, Stephen https://orcid.org/0000-0002-7394-6804
,
Carne, Emily
Edwards, Martin
Evans, Jennifer
Gardner, Jennifer
Joseph, Flora
McIldowie, Beth
Morrison, Zoe
Ponsford, Mark
Spencer, Matthew
Tully, Ian
Saw, Aung
Williams, Angharad
Williams, Hywel
Williams, Sian
Jolles, Stephen
Shortland, Graham
-
Funding
Funding for this research was provided by:
Welsh Government (All Wales Adult Syndrome Without A Name (SWAN) Service)
Association of Clinical Pathologists (Career Development Award (to M.J.P))
- License Information
-
More Information
Article History
Received: 24 September 2024
Accepted: 15 July 2025
First Online: 27 November 2025
Declarations
:
: S.J. has received support for conferences, speaker assignments, advisory board duties, clinical trials, data and safety monitoring board duties, and other projects/studies from CSL Behring, Takeda, Octapharma, Grifols, BPL, LFB, Kedrion, Pharming, Biocryst, Capitainer, Swedish Orphan Biovitrum, Biotest, Binding Site, GSK, Sanofi, UCB Pharma, and HCRW. All other authors report no potential conflicts of interest.
: The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the United States Centers for Disease Control and Prevention.
